Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and Vitrase injection
Determining the interaction of Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and Vitrase injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
Generic Name: hyaluronidase
Brand name: Amphadase, Hylenex, Vitrase, Wydase, Hydase
Synonyms: Vitrase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Vitravene
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Vitron-C
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Vituz
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Vituz Oral Solution
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Viva topical
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Vivacaine
- Vitrase injection-Kitabis Pak
- Vitrase injection-Kitabis Pak inhalation
- Vitrase injection-Klofensaid II
- Vitrase injection-Klonopin
- Vitrase injection-Klonopin Wafer
- Vitrase injection-Klonopin Wafers